Shigeru TAKAMATSU

973 total citations
43 papers, 800 citations indexed

About

Shigeru TAKAMATSU is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shigeru TAKAMATSU has authored 43 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shigeru TAKAMATSU's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Shigeru TAKAMATSU is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Shigeru TAKAMATSU collaborates with scholars based in Japan, United States and Poland. Shigeru TAKAMATSU's co-authors include Hidemi Yoshida, K. Satoh, Tadaatsu Imaizumi, Makoto Hiramoto, Kei Satoh, Yoko KAWAMURA, Donald L. Atkinson, Patrick W. Gray, Guy A. Zimmerman and Thomas M. McIntyre and has published in prestigious journals such as Journal of Clinical Investigation, Stroke and Journal of the American Geriatrics Society.

In The Last Decade

Shigeru TAKAMATSU

40 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeru TAKAMATSU Japan 14 193 166 143 125 120 43 800
Michele Nutini Italy 8 152 0.8× 226 1.4× 218 1.5× 226 1.8× 54 0.5× 9 1.0k
Concetta Di Febbo Italy 18 184 1.0× 215 1.3× 255 1.8× 221 1.8× 155 1.3× 31 1.0k
J D Sraer France 15 128 0.7× 307 1.8× 129 0.9× 43 0.3× 85 0.7× 34 1.1k
Daniel T. Price United States 5 104 0.5× 113 0.7× 204 1.4× 89 0.7× 147 1.2× 6 702
Patti Polinsky United States 7 197 1.0× 140 0.8× 130 0.9× 98 0.8× 29 0.2× 8 697
Anders Bröijersén Sweden 15 212 1.1× 121 0.7× 289 2.0× 96 0.8× 114 0.9× 27 719
Ronald K. Mayfield United States 22 155 0.8× 335 2.0× 308 2.2× 95 0.8× 130 1.1× 51 1.4k
L. Selmeci Hungary 14 123 0.6× 174 1.0× 122 0.9× 103 0.8× 32 0.3× 51 705
Mitsumine Fukui Japan 18 119 0.6× 246 1.5× 190 1.3× 45 0.4× 55 0.5× 46 1.0k
Hermann Joseph Gröne Germany 8 102 0.5× 323 1.9× 84 0.6× 78 0.6× 67 0.6× 8 863

Countries citing papers authored by Shigeru TAKAMATSU

Since Specialization
Citations

This map shows the geographic impact of Shigeru TAKAMATSU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru TAKAMATSU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru TAKAMATSU more than expected).

Fields of papers citing papers by Shigeru TAKAMATSU

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru TAKAMATSU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru TAKAMATSU. The network helps show where Shigeru TAKAMATSU may publish in the future.

Co-authorship network of co-authors of Shigeru TAKAMATSU

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru TAKAMATSU. A scholar is included among the top collaborators of Shigeru TAKAMATSU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru TAKAMATSU. Shigeru TAKAMATSU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakinuma, Ryutaro, Kazuto Ashizawa, Toshiaki Kobayashi, et al.. (2012). Comparison of sensitivity of lung nodule detection between radiologists and technologists on low-dose CT lung cancer screening images. British Journal of Radiology. 85(1017). e603–e608. 13 indexed citations
2.
Takeuchi, Mika, et al.. (2005). Dietary and genetic control of pancreatic beta cell glucose transporter-2 glycosylation promotes insulin secretion in suppressing the pathogenesis of type 2 diabetes. Glycobiology. 15(11). 1233–1234. 1 indexed citations
3.
Yoshida, Hidemi, Kei Satoh, Masayuki Koyama, Makoto Hiramoto, & Shigeru TAKAMATSU. (1996). Deficiency of plasma platelet-activating factor acetylhydrolase: Roles of blood cells. American Journal of Hematology. 53(3). 158–164. 15 indexed citations
4.
Stafforini, Diana M., K. Satoh, Donald L. Atkinson, et al.. (1996). Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.. Journal of Clinical Investigation. 97(12). 2784–2791. 226 indexed citations
5.
TAKAMATSU, Shigeru, K. Satoh, Tadaatsu Imaizumi, et al.. (1995). Effects on Health of Dietary Supplementation with 100 mg d-α-Tocopheryl Acetate, Daily for 6 Years. Journal of International Medical Research. 23(5). 342–357. 24 indexed citations
6.
Yoshida, Hidemi, Kimihiko Satoh, H. Ishida, et al.. (1994). Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes. Annals of Hematology. 69(3). 139–145. 8 indexed citations
7.
Satoh, Kei, et al.. (1994). Pyrazolopyridine Derivative Acts as a Novel Cyclooxygenase Inhibitor: Antiplatelet Effect in Aged Patients with Ischemic Stroke. Journal of the American Geriatrics Society. 42(6). 639–642. 4 indexed citations
8.
Yoshida, Hidemi, et al.. (1992). Participation of serum albumin and LDL-cholesterol in impaired blood cell-filterability affected by white blood cells in patients with cerebral thrombosis. Scandinavian Journal of Clinical and Laboratory Investigation. 52(7). 641–646. 3 indexed citations
10.
Satoh, K., et al.. (1991). Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke. Acta Neurologica Scandinavica. 83(2). 99–102. 9 indexed citations
11.
Imaizumi, Tadaatsu, Kei Satoh, Hidemi Yoshida, et al.. (1990). Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart and Vessels. 5(2). 81–86. 27 indexed citations
13.
Satoh, Kei, et al.. (1988). Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins. 35(5). 685–698. 48 indexed citations
14.
Satoh, Kei, et al.. (1979). Serum lipid peroxide in cerebrovascular diseases determined by a new colorimetric method. Nosotchu. 1(4). 313–318. 4 indexed citations
15.
Satoh, Kei, et al.. (1979). Serum LDL and VLDL Levels in Cerebrovascular Diseases. The Journal of Japan Atherosclerosis Society. 6(4). 459–466. 1 indexed citations
17.
TAKAMATSU, Shigeru, et al.. (1979). Dependence of Erythrocyte Deformability on Some Blood Constituents. Blood & Vessel. 10(4). 610–615. 1 indexed citations
18.
TAKAMATSU, Shigeru, et al.. (1978). Transient Global Amnesia : Report of Two Cases with Special Reference to Associative Symptoms. 25(1). 101–106. 2 indexed citations
19.
TAKAMATSU, Shigeru & Hisao Tominaga. (1973). On normalizers of simple ring extensions. Proceedings of the Japan Academy Series A Mathematical Sciences. 49(9). 1 indexed citations
20.
TAKAMATSU, Shigeru, et al.. (1969). AN ELECTRON MICROSCOPIC OBSERVATION OF GLUTAMIC OXALACETIC TRANSAMINASE (GOT) ACTIVITY IN THE HEART MUSCLE. Japanese Circulation Journal-english Edition. 33(10). 1142–1143. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026